Related Experiment Video
Updated: Nov 24, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
High prevalence of occult thrombosis in cases of mild/moderate COVID-19
Budong Chen1, Chunguo Jiang2, Bing Han3
1The Radiology Department, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Background And Purpose:
An increasing number of reports have observed thrombosis in severe cases of COVID-19. The aim of this study was to evaluate the incidence of thromboembolism in mild/moderate cases of COVID-19. All of the patients had normal coagulation tests and none had any overt thrombotic complications. Our findings indicate that it is important to screen the thrombotic status of cases with mild/moderate COVID-19.
Methods:
Between 11 June and 8 July 2020, 23 patients with mild/moderate COVID-19 pneumonia consented to having computed tomography pulmonary angiography (CPTA) and computed tomography venography (CTV) scans of the lungs and extremity veins. Doppler ultrasound (DUS) was also performed in all patients for screening. The incidence, clinical manifestations, laboratory examinations, imaging features, and prognosis, of patients with venous thromboembolism (VTE) were analyzed and compared with those of patients with COVID-19 pneumonia without VTE.
Results:
Nineteen patients (82.6%) had VTE, mainly distal limb thrombosis. Only one of the VTE patients was positive when screened by DUS; the other VTE patients were negative by DUS. All of the mild/moderate patients with VTE were screened by CTPA + CTV. Blood tests for inflammatory, coagulation, and biochemical, parameters were all within the normal range, except for WBC and LDH.
Conclusions:
When using CTV screening for DVT, we found that the incidence of thrombosis in patients with mild/moderate COVID-19 markedly increased to 82.6% (19/23). Screening for thrombosis is therefore important in patients with COVID-19. CTV is more sensitive than DUS for the detection of thrombosis. More research is now needed to evaluate the significance of thrombosis in COVID-19 pneumonia.
Insights
Mild/moderate COVID-19 significantly increases the risk of venous thromboembolism (VTE), with 82.6% of patients developing thrombosis. Computed tomography venography (CTV) is crucial for detecting this thrombosis in COVID-19 patients.
Area of Science:
- Medical research
- Cardiovascular science
- Infectious disease
Background:
- Thrombosis is frequently observed in severe COVID-19 cases.
- Limited data exists on thromboembolism incidence in mild/moderate COVID-19.
- Normal coagulation tests do not exclude thrombotic risk in these patients.
Purpose of the Study:
- To determine the incidence of thromboembolism in mild/moderate COVID-19.
- To compare diagnostic accuracy of imaging techniques for thrombosis detection.
- To highlight the importance of thrombotic screening in all COVID-19 cases.
Main Methods:
- 23 patients with mild/moderate COVID-19 pneumonia underwent computed tomography pulmonary angiography (CTPA) and computed tomography venography (CTV).
- Doppler ultrasound (DUS) was used for initial screening of extremity veins.
- Analysis included incidence, clinical, laboratory, imaging features, and prognosis of venous thromboembolism (VTE).
Main Results:
- A high incidence of VTE (82.6%, 19/23 patients) was detected, primarily distal limb thrombosis.
- Doppler ultrasound (DUS) showed low sensitivity, with only one VTE patient testing positive.
- Computed tomography venography (CTV) identified thrombosis in all affected patients, despite normal coagulation parameters (except WBC and LDH).
Conclusions:
- Computed tomography venography (CTV) screening revealed a markedly increased incidence of thrombosis (82.6%) in mild/moderate COVID-19.
- Screening for thrombosis is essential for all COVID-19 patients, irrespective of severity.
- CTV demonstrates superior sensitivity over DUS for detecting thrombosis in COVID-19, warranting further research into its clinical significance.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
